CV9104: Phase I/IIb completed enrollment

CureVac completed enrollment of >195 chemotherapy-naïve patients with asymptomatic or minimally symptomatic CRPC in a double-blind, placebo-controlled, European Phase I/IIb trial evaluating intraderma...